The pharma company has announced that it had secured five product patents in China, Israel, Mexico, Singapore and Sri Lanka corresponding to its new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.
Suven Life Sciences ended on a flat note at Rs. 232 on BSE today. The pharma company has announced that it had secured five product patents in China, Israel, Mexico, Singapore and Sri Lanka corresponding to its new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.
| Subscribe To Our Free Newsletter |
